Golle L, Michl C, Kreft B
Universitätsklinik und Poliklinik für Dermatologie und Venerologie, Universitätsklinikum Halle (Saale), Martin-Luther-Universität Halle-Wittenberg, Ernst-Grube-Str. 40, 06120, Halle (Saale), Deutschland.
Dermatologie (Heidelb). 2022 Dec;73(12):959-964. doi: 10.1007/s00105-022-05018-0. Epub 2022 Jun 9.
Severe, blistering, adverse drug reactions involving the skin include Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Allopurinol, anticonvulsants, sulphonamide antibiotics and non-steroidal anti-inflammatory drugs in the oxicam class have been repeatedly described as triggers. Increasingly, immunotherapies are also coming into focus as triggers of severe skin reactions. Two patients with bullous skin symptoms after administration of the checkpoint inhibitor pembrolizumab are presented. As the clinical picture does not always allow an unequivocal classification, a histological assessment is often indispensable.
涉及皮肤的严重水疱性药物不良反应包括史蒂文斯-约翰逊综合征(SJS)和中毒性表皮坏死松解症(TEN)。别嘌醇、抗惊厥药、磺胺类抗生素以及恶丙嗪类非甾体抗炎药一再被描述为引发因素。越来越多的免疫疗法也成为严重皮肤反应的引发因素。本文介绍了两名在使用检查点抑制剂派姆单抗后出现大疱性皮肤症状的患者。由于临床表现并不总是能明确分类,组织学评估往往必不可少。